The Summa Equity
Portfolio Report 2020

Investing to solve global challenges - 2020
View Report

Why Summa?

As the population and economy are growing, and technology transforms society, we are faced with increasing challenges. These challenges, however, provide tremendous opportunities as making the world more future-proof require us to adopt new and innovative solutions.

Summa seeks to invest in and develop companies that provide these solutions. Through their products or services, these companies aim to reduce climate change, mitigate resource scarcity, improve education, health and well-being or provide sustainable energy sources.

About Summa

Summa at a glance

Sector

Private Equity

Established

2016

Market Position

Mid Cap

Funds

2

Assets under mgmt

18 SEKbn

Portfolio companies

22

Investment Strategy

Thematic

Employees

~50

Recent highlights

#acquisition

Summa Equity acquires G-CON Manufacturing, the leading US-based provider of POD® cleanroom solutions

Through its acquisition of G-CON, Summa Equity enters the rapidly growing biopharmaceutical manufacturing market, including cell and gene therapy manufacturing.
#acquisition

Summa Equity acquires Axion BioSystems

Axion BioSystems is a leading life science tools company focused on developing and commercializing label-free, bioelectronic assays used to study the function of live cells in vitro, to enable drug discovery, and disease modeling.
#aquisition

Summa Equity and Longship join forces in land-based fish farming

Longship brings Summa Equity on board as an investor in Nofitech, a leading turn-key supplier of recirculating aquaculture systems (RAS), to support growth opportunities in land-based fish farming.
#acquisition

Summa Equity acquires myneva

Summa Equity Fund II, has made its first investment in Germany, acquiring myneva, one of the leading European software providers for the social care sector.
#news

Summa Equity publishes Portfolio Report 2020

We are excited to release Summa’s fourth Annual Portfolio Report! Here, we wish to showcase Summa’s culture of constant improvement – we are continuously looking to enhance the way in which we analyze and communicate the link between financial performance and value creation impact.
#aquisition

Lakers Group acquires Norsk Pumpeservice 

The acquisition is expected to close in August.
#exit

Summa Equity has agreed to sell HyTest to Mindray for €545 million

Summa Equity has signed a definitive agreement to sell HyTest to Mindray, a leading global medical technology company.
See more news

Newsletter

Stay up to date

Follow Summa Equity and our investments.
Share what we work on, how we do it and why we do it.